Literature DB >> 2359204

Better control of esophageal variceal bleeding by sclerotherapy followed by surgery.

H Ashida1, A Nishioka, M Fukuda, Y Kotoura, Y Ishikawa, J Utsunomiya.   

Abstract

This paper reports the clinical results of a retrospective study comparing endoscopic injection sclerotherapy (EIS) and back-up surgical treatment after EIS in the management of acute variceal bleeding. The 74 patients included in the study were divided into 2 groups. Group I consisted of 41 patients who received EIS over a mean period of 2.2 sessions and Group II consisted of 33 patients who underwent EIS and subsequent surgical intervention, in the form of 19 distal splenorenal shunts and 14 nonshunting procedures. The overall percentage of patients in whom initial control of variceal bleeding was achieved was 91.8 per cent. Four of the Group II patients were saved by emergency nonshunting operations. Rebleeding was experienced by 4 (28.6 per cent) of the 14 patients who underwent nonshunting surgery but by only 1 (5.3 per cent) of the 19 patients who underwent selective shunt surgery. The cumulative survival in Group II was significantly superior to that in Group I with 2 year survival being achieved in 66.7 per cent of the Group II patients but in only 23 per cent of Group I patients. Thus, the combination of initial EIS and back-up surgical intervention may be more beneficial than sclerotherapy alone for patients with acute variceal bleeding, while, the distal splenorenal shunt may be a more suitable surgical technique for patients having previously EIS.

Entities:  

Mesh:

Year:  1990        PMID: 2359204     DOI: 10.1007/bf02470659

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  26 in total

1.  Portal and mesenteric venous thrombosis as a complication of endoscopic sclerotherapy.

Authors:  H Ashida; Y Kotoura; A Nishioka; K Takagi; H Yoshikawa; Y Ishikawa; J Utsunomiya
Journal:  Am J Gastroenterol       Date:  1989-03       Impact factor: 10.864

2.  [Improvement of selectivity of distal splenorenal shunt and its clinical analysis].

Authors:  H Ashida; Y Ishikawa; Y Kotoura; K Takagi; J Utsunomiya
Journal:  Nihon Geka Gakkai Zasshi       Date:  1988-08

3.  Splenopancreatic disconnection. Improved selectivity of distal splenorenal shunt.

Authors:  W D Warren; W J Millikan; J M Henderson; K M Abu-Elmagd; J R Galloway; G T Shires; W O Richards; A A Salam; M H Kutner
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

4.  Portal hypertension. A fifteen year perspective.

Authors:  R Zeppa; P A Lee; D G Hutson; J U Levi; A S Livingstone
Journal:  Am J Surg       Date:  1988-01       Impact factor: 2.565

5.  Bleeding esophageal varices: treatment with vasopressin, transhepatic embolization and selective splenorenal shunting.

Authors:  W C Johnson; D C Nabseth; W C Widrich; H L Bush; E T O'Hara; A H Robbins
Journal:  Ann Surg       Date:  1982-04       Impact factor: 12.969

6.  Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy.

Authors:  W E Fleig; E F Stange; R Hunecke; W Schönborn; U Hurler; K Rainer; W Gaus; H Ditschuneit
Journal:  Hepatology       Date:  1987 Mar-Apr       Impact factor: 17.425

7.  Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage. Long-term follow-up.

Authors:  J P Cello; J H Grendell; R A Crass; T E Weber; D D Trunkey
Journal:  N Engl J Med       Date:  1987-01-01       Impact factor: 91.245

8.  Endoscopic injection sclerosis in bleeding gastric varices.

Authors:  W Trudeau; T Prindiville
Journal:  Gastrointest Endosc       Date:  1986-08       Impact factor: 9.427

9.  Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding. Preliminary report of a prospective, randomized trial.

Authors:  W D Warren; J M Henderson; W J Millikan; J T Galambos; W S Brooks; S P Riepe; A A Salam; M H Kutner
Journal:  Ann Surg       Date:  1986-05       Impact factor: 12.969

10.  Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial.

Authors:  D Westaby; B R Macdougall; R Williams
Journal:  Hepatology       Date:  1985 Sep-Oct       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.